← Back to directory
SP
Sofinnova Partners
Paris, FranceWebsite ↗
Sofinnova Partners is a leading European venture capital firm specializing in life sciences, with a strong focus on healthcare and sustainability. The firm actively builds companies across the entire value chain of life sciences investments, from seed to later-stage.
Last raised
Nov 2025
9 mo ago
Latest fund size
$750M
Sofinnova Capital XI
AUM
$4B
estimated
Funds raised
Capital this firm has raised, newest first
Sofinnova Capital XI
Nov 2025
$750M
Biovelocita II
Mar 2025
$180M
Sofinnova Industrial Biotech II
Jan 2021 · IB II
—
Sofinnova MD Start III
Jan 2019
—
Sofinnova Industrial Biotech I
Jan 2017 · IB I
—
Sofinnova MD Start II
Jan 2015
—
Sofinnova Green Seed Fund
Jan 2012
—
MD Start I
Jan 2008
—
Sofinnova Capital
Jan 1987
—
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Ingenix.aiLead | Seed | — | Jun 2026 | |
| CellCentric | Series D | $220M | May 2026 | |
| Signadori Bio | Seed | — | May 2026 | |
| P2 ScienceLead | Growth | $23M | May 2026 | |
| May Health | — | — | Mar 2026 | |
| Tenpoint Therapeutics | — | — | Jan 2026 | |
| T-Therapeutics | Series A | $32M | Nov 2025 | |
| Qorium | Series A | $25M | Nov 2025 |
Sources
Where this data came from